Is the Hype About a New Non-Opioid Analgesic Justified? - Pain News Network
The FDA is prioritizing the review of suzetrigine, a non-opioid analgesic developed by Vertex Pharmaceuticals, potentially marking the first new class of pain medication in over two decades. While initially hopeful, the author is concerned about the drug's efficacy and the FDA's motivations for fast-tracking it, questioning if it's another 'false flag' in the search for effective non-opioid pain treatments.
Highlighted Terms
Related News
The FDA is prioritizing the review of suzetrigine, a non-opioid analgesic developed by Vertex Pharmaceuticals, potentially marking the first new class of pain medication in over two decades. While initially hopeful, the author is concerned about the drug's efficacy and the FDA's motivations for fast-tracking it, questioning if it's another 'false flag' in the search for effective non-opioid pain treatments.